Opening book details…
About this Medicine article
Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicener, double-blind, randomized controlled trial in China by Li, Xiaoke; Zhang, Ludan; Qiu, Mei; Huang, Yi; Xiao, Huanming; Lu, Bingjiu; Jiang, Yuyong; Long, Fuli; Lin, Hui; He, Jinyu; Wu, Qikai; Zhang, Mingxiang; Wang, Li; Zhu, Xiaoning; Gong, Man; Sun, Xuehua; Sun, Jianguang; Sun, Fengxia; Lu, Wei; Xu, Weihua; Chen, Guang; Li, Zhiguo; Gan, Danan; Yang, Xianzhao; Du, Hongbo; Ye, Yongâan is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Li, Xiaoke; Zhang, Ludan; Qiu, Mei; Huang, Yi; Xiao, Huanming; Lu, Bingjiu; Jiang, Yuyong; Long, Fuli; Lin, Hui; He, Jinyu; Wu, Qikai; Zhang, Mingxiang; Wang, Li; Zhu, Xiaoning; Gong, Man; Sun, Xuehua; Sun, Jianguang; Sun, Fengxia; Lu, Wei; Xu, Weihua; Chen, Guang; Li, Zhiguo; Gan, Danan; Yang, Xianzhao; Du, Hongbo; Ye, Yongâan
- Publisher
- BioMed Central; Springer (Biomed Central Ltd.); Current Controlled Trials Ltd.; [London]: BioMed Central, 2006-; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1468-6708)
- Published
- 2020
- Field
- Medicine (Health Sciences)